{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:24:14Z","timestamp":1787509454065,"version":"build-2736575974"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3502000"],"award-info":[{"award-number":["2022YFC3502000"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","award":["ZYYCXTDD-202004"],"award-info":[{"award-number":["ZYYCXTDD-202004"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015796","name":"Shanghai Lingjun Program","doi-asserted-by":"publisher","award":["22YF1441500"],"award-info":[{"award-number":["22YF1441500"]}],"id":[{"id":"10.13039\/100015796","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273897"],"award-info":[{"award-number":["82273897"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274011"],"award-info":[{"award-number":["82274011"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U23A20516"],"award-info":[{"award-number":["U23A20516"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82141203"],"award-info":[{"award-number":["82141203"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204606"],"award-info":[{"award-number":["82204606"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2022CX005"],"award-info":[{"award-number":["2022CX005"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.bioorg.2025.108560","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T19:09:27Z","timestamp":1746817767000},"page":"108560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Discovery of baicalein derivatives as novel covalent inhibitors of SARS CoV-2 Mpro: Structure-activity relationships and inhibitory mechanisms"],"prefix":"10.1016","volume":"161","author":[{"given":"Zhao-Qin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Hao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Xuan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Zhu","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ni","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Qing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Dong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yu","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Bing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Bo","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108560_bb0005","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1038\/s41467-020-16954-7","article-title":"Structural plasticity of SARS-CoV-2 3CL M(pro) active site cavity revealed by room temperature X-ray crystallography","volume":"11","author":"Kneller","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108560_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111313","article-title":"An update review of emerging small-molecule therapeutic options for COVID-19","volume":"137","author":"Tian","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.108560_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijbiomac.2021.02.071","article-title":"Potential drug targets of SARS-CoV-2: from genomics to therapeutics","volume":"177","author":"Shamsi","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.108560_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20240015","article-title":"MALDI-TOF MS analysis of nasal swabs for the characterization of patients infected with SARS-CoV-2 omicron","volume":"5","author":"Song","year":"2024","journal-title":"View"},{"issue":"2022","key":"10.1016\/j.bioorg.2025.108560_bb0025","article-title":"The SARS-CoV-2 main protease (M(pro)): structure, function, and emerging therapies for COVID-19","volume":"3","author":"Hu","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.bioorg.2025.108560_bb0030","doi-asserted-by":"crossref","first-page":"12500","DOI":"10.1021\/acs.jmedchem.2c01005","article-title":"Targeting SARS-CoV-2 Main protease for treatment of COVID-19: covalent inhibitors structure-activity relationship insights and evolution perspectives","volume":"65","author":"La Monica","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108560_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115491","article-title":"The research progress of SARS-CoV-2 main protease inhibitors from 2020 to 2022","volume":"257","author":"Pang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108560_bb0040","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.108560_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061578","article-title":"Natural products for drug discovery in the 21st century: innovations for novel drug discovery","volume":"19","author":"Thomford","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108560_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28093690","article-title":"Natural products for drug discovery in the 21st century: innovations for novel therapeutics","volume":"28","author":"Coy-Barrera","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108560_bb0055","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"International natural product sciences, C.T. Supuran, natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.108560_bb0060","first-page":"195","article-title":"Progress in approved drugs from natural product resources, Chin","volume":"22","author":"Luo","year":"2024","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.bioorg.2025.108560_bb0065","first-page":"801","article-title":"Sustainable utilization of precious Chinese medicines: challenges and the road ahead, Chin","volume":"20","author":"Gong","year":"2022","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.bioorg.2025.108560_bb0070","first-page":"383","article-title":"Deciphering suppressive effects of Lianhua Qingwen capsule on COVID-19 and synergistic effects of its major botanical drug pairs, Chin","volume":"21","author":"Chen","year":"2023","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.bioorg.2025.108560_bb0075","doi-asserted-by":"crossref","unstructured":"L. Zhang, J. Yu, Y. Zhou, M. Shen, L. Sun, Becoming a Faithful Defender: Traditional Chinese Medicine against Coronavirus Disease 2019 (COVID-19), Am. J. Chin. Med., 48 (2020) 763\u2013777, Doi: https:\/\/doi.org\/10.1142\/S0192415X2050038X.","DOI":"10.1142\/S0192415X2050038X"},{"key":"10.1016\/j.bioorg.2025.108560_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.jff.2020.104146","article-title":"Phytochemicals containing biologically active polyphenols as an effective agent against Covid-19-inducing coronavirus","volume":"73","author":"Chojnacka","year":"2020","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.bioorg.2025.108560_bb0085","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1021\/jm070295s","article-title":"Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus","volume":"50","author":"Wen","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108560_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111596","article-title":"Antiviral activities of flavonoids","volume":"140","author":"Badshah","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.108560_bb0095","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2174\/0929867327666200713184138","article-title":"Recent research on flavonoids and their biomedical applications","volume":"28","author":"Wen","year":"2021","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108560_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109211","article-title":"Roles of flavonoids against coronavirus infection","volume":"328","author":"Russo","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bioorg.2025.108560_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173759","article-title":"Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CL(pro) and PL(pro)), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)","volume":"891","author":"Mouffouk","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108560_bb0110","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1016\/j.apsb.2022.07.017","article-title":"Schaftoside inhibits 3CL(pro) and PL(pro) of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19","volume":"12","author":"Yi","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.108560_bb0115","doi-asserted-by":"crossref","DOI":"10.26599\/FMH.2025.9420058","article-title":"The improvement effect of ellagic acid and urolithins on metabolic diseases: pharmacology and mechanism","author":"Wang","year":"2025","journal-title":"Food & Medicine Homology"},{"key":"10.1016\/j.bioorg.2025.108560_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107602","article-title":"Plant flavonoid inhibition of SARS-CoV-2 main protease and viral replication","volume":"26","author":"Lin","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.bioorg.2025.108560_bb0125","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.joim.2022.08.001","article-title":"Potential medicinal plants involved in inhibiting 3CL(pro) activity: a practical alternate approach to combating COVID-19","volume":"20","author":"Yang","year":"2022","journal-title":"J. Integr. Med."},{"key":"10.1016\/j.bioorg.2025.108560_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2020.131761","article-title":"Advances in developing small molecule SARS 3CL(pro) inhibitors as potential remedy for corona virus infection","volume":"77","author":"Konwar","year":"2021","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2025.108560_bb0135","article-title":"Eupatin, a flavonoid, inhibits coronavirus 3CL protease and replication","volume":"24","author":"Park","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108560_bb0140","first-page":"65","article-title":"Flavonoids from the roots and rhizomes of Sophoratonkinensis and their in vitro anti-SARS-CoV-2 activity, Chin","volume":"21","author":"Li","year":"2023","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.bioorg.2025.108560_bb0145","article-title":"Identification of SARS-CoV-2 3CL protease inhibitors by a quantitative high-throughput screening","author":"Zhu","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.bioorg.2025.108560_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2021.104909","article-title":"Discovery of naturally occurring inhibitors against SARS-CoV-2 3CL(pro) from Ginkgo biloba leaves via large-scale screening","volume":"152","author":"Xiong","year":"2021","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bioorg.2025.108560_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133523","article-title":"Discovery of baicalein derivatives as novel inhibitors against human pancreatic lipase: structure-activity relationships and inhibitory mechanisms","volume":"275","author":"Qin","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.108560_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2023.102326","article-title":"Protocol for production and purification of SARS-CoV-2 3CL(pro)","volume":"4","author":"Mazzei","year":"2023","journal-title":"STAR Protoc"},{"issue":"24","key":"10.1016\/j.bioorg.2025.108560_bb0165","doi-asserted-by":"crossref","first-page":"8295","DOI":"10.1016\/j.bmc.2006.09.014","article-title":"Binding interaction of quercetin-3-beta-galactoside and its synthetic derivatives with SARS-CoV 3CL(pro): structure-activity relationship studies reveal salient pharmacophore features","volume":"14","author":"Chen","year":"2006","journal-title":"Bioorganic & medicinal chemistry"},{"key":"10.1016\/j.bioorg.2025.108560_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154796","article-title":"Discovery and characterization of the covalent SARS-CoV-2 3CL(pro) inhibitors from Ginkgo biloba extract via integrating chemoproteomic and biochemical approaches","volume":"114","author":"Zhang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bioorg.2025.108560_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.130968","article-title":"3CL(pro) and PL(pro) affinity, a docking study to fight COVID19 based on 900 compounds from PubChem and literature. Are there new drugs to be found?","volume":"1245","author":"Steklac","year":"2021","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108560_bb0180","doi-asserted-by":"crossref","first-page":"12800","DOI":"10.1080\/07391102.2021.1977181","article-title":"In silico and in vitro assays reveal potential inhibitors against 3CL(pro) main protease of SARS-CoV-2","volume":"40","author":"Iype","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.108560_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114130","article-title":"In silico screening-based discovery of novel covalent inhibitors of the SARS-CoV-2 3CL protease","volume":"231","author":"Xiong","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108560_bb0190","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/cbf.3753","article-title":"Inhibition of nonstructural protein 15 of SARS-CoV-2 by golden spice: a computational insight","volume":"40","author":"Singh","year":"2022","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.bioorg.2025.108560_bb0195","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1080\/07391102.2020.1766572","article-title":"Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors","volume":"39","author":"Bhardwaj","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.108560_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104631","article-title":"Identification of potential plant bioactive as SARS-CoV-2 spike protein and human ACE2 fusion inhibitors","volume":"136","author":"Singh","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.bioorg.2025.108560_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2020.128933","article-title":"An in-silico evaluation of different bioactive molecules of tea for their inhibition potency against non structural protein-15 of SARS-CoV-2","volume":"346","author":"Sharma","year":"2021","journal-title":"Food Chemistry"},{"key":"10.1016\/j.bioorg.2025.108560_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/foods10071503","article-title":"Potential in vitro inhibition of selected plant extracts against SARS-CoV-2 Chymotripsin-like protease (3CL(pro)) activity","volume":"10","author":"Guijarro-Real","year":"2021","journal-title":"Foods"},{"key":"10.1016\/j.bioorg.2025.108560_bb0215","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1038\/s41467-021-23751-3","article-title":"Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease","volume":"12","author":"Su","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108560_bb0220","first-page":"563","article-title":"Scutellaria baicalensis: a promising natural source of antiviral compounds for the treatment of viral diseases, Chin","volume":"21","author":"Huang","year":"2023","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.bioorg.2025.108560_bb0225","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/s41467-021-22362-2","article-title":"Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors","volume":"12","author":"Iketani","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108560_bb0230","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/s41467-022-29413-2","article-title":"Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.108560_bb0235","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/cbdd.14296","article-title":"Design and synthesis of isatin derivatives as effective SARS-CoV-2 3CL protease inhibitors","volume":"102","author":"Bao","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2025.108560_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130377","article-title":"Discovery of natural catechol derivatives as covalent SARS-CoV-2 3CL(pro) inhibitors","volume":"264","author":"Wang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.108560_bb0245","article-title":"Synthesis and biochemical evaluation of 8H-Indeno[1,2-d]thiazole derivatives as novel SARS-CoV-2 3CL protease inhibitors","volume":"27","author":"Wu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108560_bb0250","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1038\/s41598-023-34883-5","article-title":"Author correction: the 8-bromobaicalein inhibited the replication of dengue, and Zika viruses and targeted the dengue polymerase","volume":"13","author":"Boonyasuppayakorn","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2025.108560_bb0255","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jpha.2020.03.009","article-title":"Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants","volume":"10","author":"Qamar","year":"2020","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.bioorg.2025.108560_bb0260","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ptr.7772","article-title":"Multi-target approach against SARS-CoV-2 by stone apple molecules: a master key to drug design","volume":"38","author":"Singh","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bioorg.2025.108560_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104965","article-title":"Potential of turmeric-derived compounds against RNA-dependent RNA polymerase of SARS-CoV-2: an in-silico approach","volume":"139","author":"Singh","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.bioorg.2025.108560_bb0270","doi-asserted-by":"crossref","unstructured":"C. Jiang, K. Jiang, X. Li, N. Zhang, W. Zhu, L. Meng, Y. Zhang, S. Lu, Evaluation of immunoprotection against coronavirus disease 2019: Novel variants, vaccine inoculation, and complications, J Pharm Anal, 13 (2023) 1\u201310, Doi: https:\/\/doi.org\/10.1016\/j.jpha.2022.10.003.","DOI":"10.1016\/j.jpha.2022.10.003"},{"key":"10.1016\/j.bioorg.2025.108560_bb0275","first-page":"797","article-title":"Discovery and characterization of naturally occurring covalent inhibitors of SARS-CoV-2 M(pro) from the antiviral herb Ephedra, Chin","volume":"22","author":"Hu","year":"2024","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.bioorg.2025.108560_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2021.131594","article-title":"Inhibition of the SARS-CoV-2 3CL(pro) main protease by plant polyphenols","volume":"373","author":"Bahun","year":"2022","journal-title":"Food Chem."},{"key":"10.1016\/j.bioorg.2025.108560_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.583387","article-title":"Plant products as inhibitors of coronavirus 3CL protease","volume":"12","author":"Mandal","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108560_bb0290","doi-asserted-by":"crossref","DOI":"10.26599\/FMH.2024.9420016","article-title":"Flavonoid-rich mulberry leaf extract modulate lipid metabolism, antioxidant capacity, and gut microbiota in high-fat diet-induced obesity: potential roles of FGF21 and SOCS2","volume":"1","author":"Liu","year":"2024","journal-title":"Food & Medicine Homology"},{"key":"10.1016\/j.bioorg.2025.108560_bb0295","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jpha.2023.04.008","article-title":"Dock-able linear and homodetic di, tri, tetra and pentapeptide library from canonical amino acids: SARS-CoV-2 Mpro as a case study","volume":"13","author":"Ahmad","year":"2023","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.bioorg.2025.108560_bb0300","doi-asserted-by":"crossref","first-page":"16584","DOI":"10.1021\/acsomega.1c01797","article-title":"Inhibition of the 3CL protease and SARS-CoV-2 replication by Dalcetrapib","volume":"6","author":"Niesor","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2025.108560_bb0305","doi-asserted-by":"crossref","first-page":"21883","DOI":"10.1021\/jacs.0c10770","article-title":"Proton-coupled conformational activation of SARS coronavirus Main proteases and opportunity for designing small-molecule broad-Spectrum targeted covalent inhibitors","volume":"142","author":"Verma","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.108560_bb0310","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jcis.2024.04.104","article-title":"Introducing Br, K, and cyano group into carbon nitride for efficient photocatalytic hydrogen peroxide production then in situ tetracycline mineralization","volume":"667","author":"Fang","year":"2024","journal-title":"J. Colloid Interface Sci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825004407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T13:15:24Z","timestamp":1753449324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825004407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":62,"alternative-id":["S0045206825004407"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108560","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of baicalein derivatives as novel covalent inhibitors of SARS CoV-2 Mpro: Structure-activity relationships and inhibitory mechanisms","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108560","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108560"}}